| MolName | 1-[3-[(E)-2-cyano-3-[(1,1-dioxothiolan-3-yl)amino]-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide |
| MolecularFormula | C22H24N6O5S |
| Smiles | NC(C(CC1)CCN1C(N=C1N2C=CC=C1)=C(/C=C(/C(NC(CC1)CS1(=O)=O)=O)\C#N)C2=O)=O |
| InChI | InChI=1S/C22H24N6O5S/c23-12-15(21(30)25-16-6-10-34(32,33)13-16)11-17-20(27-8-4-14(5-9-27)19(24)29)26-18-3-1-2-7-28(18)22(17)31/h1-3,7,11,14,16H,4-6,8-10,13H2,(H2,24,29)(H,25,30)/t16-/m1/s1 |
| InChIK | NDTQGCKQCQJXLZ-MRXNPFEDSA-N |
| TotalMolweight | 484.536 |
| Molweight | 484.536 |
| MonoisotopicMass | 484.152889 |
| CLogP | -1.4943 |
| CLogS | -3.426 |
| H Acceptors | 11 |
| H Donors | 2 |
| TotalSurfaceArea | 348.54 |
| Relative PSA | 0.36323 |
| PolarSurfaceArea | 174.41 |
| Druglikeness | 1.5449 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.47059 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Sp3Atoms | 10 |
| Symmetricatoms | 3 |
| Amides | 3 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 1-[3-[(E)-2-cyano-3-[(1,1-dioxothiolan-3-yl)amino]-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide | 2 - 1-[3-[(E)-2-cyano-3-[(1,1-dioxothiolan-3-yl)amino]-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide